| pubmed-article:15868311 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15868311 | lifeskim:mentions | umls-concept:C0376298 | lld:lifeskim |
| pubmed-article:15868311 | lifeskim:mentions | umls-concept:C0441833 | lld:lifeskim |
| pubmed-article:15868311 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:15868311 | lifeskim:mentions | umls-concept:C0033860 | lld:lifeskim |
| pubmed-article:15868311 | lifeskim:mentions | umls-concept:C1999270 | lld:lifeskim |
| pubmed-article:15868311 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:15868311 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:15868311 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:15868311 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:15868311 | pubmed:dateCreated | 2005-9-20 | lld:pubmed |
| pubmed-article:15868311 | pubmed:abstractText | Approximately 2% of people worldwide have psoriasis, with as many as 1 million people with psoriasis in Canada alone.1,2 The severity of psoriasis ranges from mild to severe. It can lead to substantial morbidity and psychological stress and have a profound negative impact on patient quality of life.3,4 Although available therapies reduce therapies reduce the extent and severity of the disease and improve quality of life,3 reports have indicated a patient preference for more aggressive therapy and a dissatisfaction with the effectiveness of current treatment options.5 | lld:pubmed |
| pubmed-article:15868311 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15868311 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15868311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15868311 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15868311 | pubmed:issn | 1203-4754 | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:LangleyRichar... | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:ShearNeil HNH | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:HoVincentV | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:GuentherLynL | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:BissonnetteRo... | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:LyndeCharlesC | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:PappKimK | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:PoulinYvesY | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:MurrayEileenE | lld:pubmed |
| pubmed-article:15868311 | pubmed:author | pubmed-author:ZipCatherineC | lld:pubmed |
| pubmed-article:15868311 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15868311 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:15868311 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15868311 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15868311 | pubmed:pagination | 321-37 | lld:pubmed |
| pubmed-article:15868311 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:meshHeading | pubmed-meshheading:15868311... | lld:pubmed |
| pubmed-article:15868311 | pubmed:articleTitle | Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004. | lld:pubmed |
| pubmed-article:15868311 | pubmed:affiliation | Department of Dermatology, University of Western Ontario, London, Ontario, Canada. dgue@uwo.ca | lld:pubmed |
| pubmed-article:15868311 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15868311 | pubmed:publicationType | Consensus Development Conference | lld:pubmed |
